Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-07-26

FDA Approved: VASCEPA — Original Application (Amarin Pharma Inc.)

View source ↗

Summary

FDA approved Vascepa (icosapent ethyl) under its Original Application for use in adults with severe hypertriglyceridemia to reduce triglyceride levels. The prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vascepa (icosapent ethyl)

Snippet

ORIG AP for VASCEPA (ICOSAPENT ETHYL)